VBI Vaccines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2002
Revenue	8.68	1.08	0.63	1.06	2.22	Upgrade
Revenue Growth (YoY)	702.40%	71.47%	-40.53%	-52.23%	-33.80%	Upgrade
Cost of Revenue	12.51	11.28	10.77	9.17	7.9	Upgrade
Gross Profit	-3.83	-10.19	-10.14	-8.11	-5.68	Upgrade
Selling, General & Admin	42.14	56.12	38.34	20.65	14.09	Upgrade
Research & Development	9.34	15.51	19.56	14.86	26.33	Upgrade
Other Operating Expenses	24.6	0	0	0	6.29	Upgrade
Operating Expenses	76.09	71.63	57.89	35.51	46.72	Upgrade
Operating Income	-79.91	-81.82	-68.03	-43.62	-52.4	Upgrade
Interest Expense / Income	6.4	4.01	4.73	2.71	2.2	Upgrade
Other Expense / Income	6.52	27.48	-3.01	-0.1	0.22	Upgrade
Pretax Income	-92.84	-113.3	-69.75	-46.23	-54.81	Upgrade
Net Income	-92.84	-113.3	-69.75	-46.23	-54.81	Upgrade
Preferred Dividends	1.01	0	0	0	0	Upgrade
Net Income Common	-93.84	-113.3	-69.75	-46.23	-54.81	Upgrade
Shares Outstanding (Basic)	16	9	8	7	4	Upgrade
Shares Outstanding (Diluted)	16	9	8	7	4	Upgrade
Shares Change	80.90%	1.30%	16.80%	82.73%	81.95%	Upgrade
EPS (Basic)	-6.03	-13.16	-8.10	-6.30	-13.80	Upgrade
EPS (Diluted)	-6.03	-13.16	-8.10	-6.30	-13.80	Upgrade
Free Cash Flow	-61.75	-78.04	-41.9	-48.05	-52.39	Upgrade
Free Cash Flow Per Share	-3.96	-9.06	-4.93	-6.60	-13.16	Upgrade
Gross Margin	-44.06%	-942.14%	-1606.81%	-764.09%	-255.88%	Upgrade
Operating Margin	-920.42%	-7561.92%	-10781.62%	-4110.93%	-2359.25%	Upgrade
Profit Margin	-1080.87%	-10471.63%	-11054.36%	-4357.21%	-2467.94%	Upgrade
Free Cash Flow Margin	-711.24%	-7212.48%	-6640.73%	-4528.75%	-2358.62%	Upgrade
EBITDA	-84.45	-107.24	-63.19	-41.87	-51.41	Upgrade
EBITDA Margin	-972.64%	-9910.81%	-10013.63%	-3946.28%	-2314.86%	Upgrade
Depreciation & Amortization	1.99	2.06	1.84	1.65	1.2	Upgrade
EBIT	-86.44	-109.3	-65.02	-43.52	-52.62	Upgrade
EBIT Margin	-995.57%	-10101.29%	-10304.44%	-4101.98%	-2369.07%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).